Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide
Autor: | Chi‐Ming Tai, Ming‐Lung Yu |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Kaohsiung Journal of Medical Sciences, Vol 40, Iss 2, Pp 112-118 (2024) |
Druh dokumentu: | article |
ISSN: | 2410-8650 1607-551X |
DOI: | 10.1002/kjm2.12788 |
Popis: | Abstract With the introduction of direct‐acting antivirals, elimination of hepatitis C virus (HCV) infection is becoming possible. People who inject drugs (PWID) represent a population with a high risk for HCV infection, which has been reported as high as 90% in Taiwanese PWID. To reach the goal of HCV elimination, PWID is a key population deserving special attention. Barriers in HCV care cascade still exist in PWID, and interventions to promote access to HCV diagnosis, link‐to‐care, treatment, and prevention for PWID are warranted. Although HCV micro‐elimination can be achieved in some prisons and opioid substitution therapy (OST) centers by a multidisciplinary team and integrated care in Taiwan, there are still several unmet needs for HCV elimination in PWID. Continuous efforts, such as the participation of OST specialists and the continuum of care for HCV among PWID, are needed to achieve HCV elimination in Taiwan. In addition, the combination of harm reduction services, treatment as prevention and regular posttreatment HCV surveillance is critical to substantially reduce HCV transmission and prevalence in PWID. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |